Complete Remission of Cavin-4 Immunoglobulin G Rippling Muscle Disease After Rituximab Therapy
By
Tony Zhang, MBChB1; William J. Litchy, MD1; Divyanshu Dubey, MD1,2
1d ago· 3 min readNews
Source

This case report describes a 65-year-old man who experienced complete remission of cavin-4 immunoglobulin G (IgG) rippling muscle disease after receiving rituximab therapy.
You might also wanna read
Third Death in Sarepta Gene Therapy Trial for Limb-Girdle Muscular Dystrophy
A 51-year-old patient in a Phase I study of Sarepta's gene therapy for Limb-Girdle muscular dystrophy Type 2E has died from acute liver toxi
Can Myositis Go Into Remission?
Cleveland Clinic·1mo ago
A man and a woman with a rare and devastating autoimmune disease have been in remission for more than 15 years after receiving a stem-cell transplant
go.nature.com
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic

Cinco decisiones al despertar que podrían influir en el intestino, el estrés y la respuesta inmune
Infobae·3h ago
RT @scottisaacsmd: Apitegromab, a selective antimyostatin monoclonal antibody targeting muscle preservation, added to tirzepatide reduced m…
nature.com·7d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.